CAR-T cells produce antibodies against rheumatoid arthritis
Chimeric antigen receptor (CAR) T cells are increasingly being tested in treatment-refractory rheumatoid arthritis. Recently, they have been engineered to function as on-site factories for therapeutic anti-cytokine antibodies.
Arzte zeitung
